Ratings by Morgan Stanley (Terance Flynn)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2026 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/9/2026 | Amgen | AMGN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/1/2026 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/10/2026 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/4/2026 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/12/2025 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/5/2025 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/6/2025 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/26/2024 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/11/2024 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/7/2024 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/3/2024 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/9/2024 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/7/2024 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/1/2023 | Amgen | AMGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/17/2023 | Amgen | AMGN | New Coverage | Equalweight (N/A) |
284.10 (425.28) |
49.69% | Details |
